Stereotaxis, Inc. (STXS)
1.79
-0.03
(-1.65%)
USD |
NYAM |
Mar 20, 16:00
1.785
0.00 (0.00%)
After-Hours: 20:00
Stereotaxis Research and Development Expense (Quarterly) : 2.71M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Myomo, Inc. | 1.625M |
| TransMedics Group, Inc. | 20.70M |
| CONMED Corp. | 14.90M |
| Dynatronics Corp. | -- |
| Escalon Medical Corp. | 0.1312M |